Cargando...

An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States

INTRODUCTION: The treatment with tyrosine kinase inhibitors (TKIs) has drastically improved the outcome of chronic myeloid leukemia (CML) patients. This study was conducted to examine the risk of secondary cancers (SCs) in the CML patients who were diagnosed and treated in the TKI era in the United...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PeerJ
Autores principales: Kumar, Vivek, Garg, Mohit, Chaudhary, Neha, Chandra, Abhinav Binod
Formato: Artigo
Lenguaje:Inglês
Publicado: PeerJ Inc. 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813591/
https://ncbi.nlm.nih.gov/pubmed/29456888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.4342
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!